EDIL3 and hepatocellular carcinoma: Xia et al. (2015) reported that EDIL3 can promote HCC invasion and migration through the induction of epithelial-mesenchymal transition (EMT). Zou et al. (2009) demonstrated that EDIL3 accelerates tumor growth by stimulating angiogenesis in colon cancer.